AIM 3: Validation through Collaboration
Validate existing and new markers developed in AIMS 1-2 in other disease-based cohorts, and explore their prevalence and predictive utility within established early disease and pre-symptomatic cohorts.
GEMINI / ONDRI Collaboration
ONDRI is excited to embark on a collaboration with St. Michael’s Hospital’s General Medicine Inpatient Initiative (GEMINI). GEMINI is a “Big Data” research enterprise in General Internal Medicine (GIM).
Over the next year we will be using all available GEMINI data — from admission to discharge — with the goal of training and testing an automated AI tool to identify delirium during hospitalization
We would like to congratulate our GEMINI collaborators (led by Fahad Razak) who were recently awarded a CHRP grant for their work on delirium!
Canadian Consortium on Neurodegenerative Diseases and Aging (CCNA)
The Canadian Consortium on Neurodegeneration in Aging (CCNA) was established in 2014 as part of Canada’s commitment to the 38th G8 Summit. The CCNA leverages Canadian strengths in multidisciplinary research, takes collaborative team-based approaches to scientific progress, and strikes a balance between research on care and cure.
It is important to note that the majority of the CCNA’s research teams are testing their hypotheses through its signature study, COMPASS-ND, where they harness national platforms and cohorts of research participants to share data and disseminate results to the public, clinicians, and policymakers.
BEAM (Brain-Eye Amyloid)
Dancing with Parkinsons